| Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Dead Body Stinks from the Head |
|
Other Articles - Dead Body Stinks from the Head
A key reason for companies’ downhill slide is undoubtedly the quality of CEO. Most
turnaround situations arise because of the CEO’s incompetence, ineptness, carelessness,
ego and /or inexperience. It is simply too According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product much to ask or expect the incumbent
management to be objective in evaluating its past performance when the CEO is probably
the same person whose mismanagement caused the company’s financial health to
deteriorat ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in in the first place. The problem is that some CEOs may lack training even
though they may think they know it all. Sir John Harvey Jones said that the reason many companies always find themselves in trouble is alm lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ost always due to the problems right at the top. Sir John Harvey-Jones is
one of Britain’s best-known and most respected business leaders. Besides being the
Chairman of ICI he won the fame as the star of the BBC T here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe series ‘Troubleshooter.’
Harvard’s Professor Rosabeth Moss Kanter, whose work focuses on leadership of
turnarounds pointed out in the Economic and Social Research Council lecture in London:
“Formal structures a d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro d process undergird confidence, but what also matters is the
willingness of leaders to believe in people and give them opportunities to share. Behind
every winning streak are leaders who care about the team. That ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc is why new leaders are
often required to lead turnarounds.” Michael Dell of Dell Computers said, “When a
business goes wrong, look only to the people who are running it.” Sun Tzu acknowledged the critical role pl easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi yed by generals or CEOs when he said:
“When the general is weak and without authority, when his orders are not clear and
distinct, when there are no fixed duties assigned to officers and men and the ranks are
fo nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically rmed in a slovenly haphazard manner, the result is utter disorganisation. Many early ventures into China fared miserably as these companies sent the wrong managers to run the operations there. By merely having a lo and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ al staff or secretary to
handle the Chinese relations is insufficient. Companies should send managers with
excellent managerial skills as well as those with excellent understanding of China market.
Volkswagen an ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi Siemens hired some excellent CEOs who were able to transform their
loss-making joint ventures into successful ones. General Motors sent one of its best
people to China in the mid-1990s and is now very successful, ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a even being linked to the
Shanghai Automotive Industry Corporation. Toyota is sending its expatriates for sixmonth
or longer on language courses to prepare them for the China assignments. The
crux is to have the dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod best key man in place. People often confuse the differences between leaders with managers and use those terms interchangeably. Managers do things right, while leaders do the right thing. Managers tend to focus on cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin short-term goals and objectives and administer them. On the other hand,
leaders also consider such issues as well as other long-term issues to inspire and innovate
their staff. Managers act and think incrementall tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen whilst leaders think and act radically. A
leader is someone that will attract other people to follow them voluntarily whereas a
manager demands to be obeyed. Whilst the manager uses official and formal
communic t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel tion and procedure, the leader uses passion and stirs up the emotion of the
people. Leadership matters. John Maxwell, an author on several books on leadership said: “Everything rises and falls on leadership.” And ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust it matters more in times of uncertainty
than in times of stability. Leadership is not a fad. It is here today and forever. Leadership is an observable set of skills and abilities. Leadership takes precedence bec y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products use it is the top management who decides what need to be done and the ones who
make things happen. It is true that one person alone cannot change the world, or even a
moderate-sized organisation. It takes the conc . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de entrated energy, ideas and enthusiasm of
many people. But without a leader, the movement does not get started in the first place,
or it quickly fizzles off for lack of direction or momentum. Without leaders, good elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip esults
are a matter of random chance and therefore unsustainable. Change requires leadership
and will not happen by default. Leadership is the backbone around which all the rest of
the corporate body takes shape tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Just What Are Consumers Thinking? Non-Woven Textile Market - An Introduction
|